Boston Scientific Equity Method Investment Basis Difference decreased by 10.9% to $334.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.7%, from $374.00M to $334.00M.
Large differences may indicate significant intangible assets or goodwill embedded within the investment value.
The difference between the carrying value of an investment accounted for under the equity method and the company's share...
Commonly reported by firms with significant minority stakes in joint ventures or strategic partners.
equity_method_investments_basis_diff| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $314.00M | $289.00M | $237.00M | $233.00M | $242.00M | $209.00M | $230.00M | $236.00M | $237.00M | $233.00M | $255.00M | $374.00M | $321.00M | $375.00M | $334.00M |
| QoQ Change | — | -8.0% | -18.0% | -1.7% | +3.9% | -13.6% | +10.0% | +2.6% | +0.4% | -1.7% | +9.4% | +46.7% | -14.2% | +16.8% | -10.9% |
| YoY Change | — | — | — | -25.8% | -16.3% | -11.8% | -1.3% | -2.5% | +13.4% | +1.3% | +8.1% | +57.8% | +37.8% | +47.1% | -10.7% |